Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,414 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,414

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

for

KSHV Inflammatory Cytokine Syndrome (KICS),

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06052618

Phase2, Recruiting

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

for

Pancreatic Cancer, Gastric Cancer, Gastrointestinal Cancer,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT03190941

Phase1, Phase2, Recruiting

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

for

Peripheral Blood Stem Cell Transplantation,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT05436418

Phase1, Phase2, Recruiting

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

for

Glioma, Medulloblastoma, Ependymoma, Glioblastoma

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06161519

Phase1, Phase2, Recruiting

Men at High Genetic Risk for Prostate Cancer

for

Prostatic Neoplasms

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: Male

Age: 30 - 70+

Code: NCT03805919

Recruiting

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

for

Attention Deficit Hyperactivity Disorder

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 8 - 16

Code: NCT05608434

Phase1, Phase2, Recruiting

Study of Chediak-Higashi Syndrome

for

Chediak-Higashi Syndrome

Location: Bethesda MD

Sponsor: National Human Genome Research Institute (NHGRI)

Sex: All

Age: 0 - 70

Code: NCT00005917

Recruiting

Effects of Treatments on Atopic Dermatitis

for

Eczema, Dermatitis, Skin Diseases, Genetic, Dermatitis, Atopic,

Location: Bethesda MD

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 2 - 50

Code: NCT01631617

Phase2, Recruiting

Clinical and Molecular Studies in Families With Inherited Eye Disease

for

Inherited Eye Disease

Location: Bethesda MD, La Jolla CA

Sponsor: National Eye Institute (NEI)

Sex: All

Age: 4 - 70+

Code: NCT02771236

Recruiting

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

for

Costello Syndrome, Noonan Syndrome,

Location: Bethesda MD, Rockville MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 70+

Code: NCT04888936

Recruiting

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

for

Obesity, Type 2 Diabetes

Location: Bethesda MD, Washington D.C. DC

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Sex: All

Age: 12 - 25

Code: NCT06730113

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

for

Advanced Solid Tumors, Metastatic Pancreatic Cancer,

Location: Bethesda MD, Fairway KS

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 12 - 70+

Code: NCT04222413

Phase1, Recruiting

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

for

Malaria

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 54

Code: NCT06607003

Phase1, Recruiting

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

for

Systemic Lupus Erythematosus (Sle)

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: Female

Age: 18 - 70+

Code: NCT06032923

Phase1, Phase2, Recruiting

Studies of the Natural History of Rheumatic Diseases

for

Rheumatic Diseases, Arthritis

Location: Bethesda MD

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 18 - 70+

Code: NCT00024479

Recruiting

Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease

for

Rheumatic Disease

Location: Bethesda MD

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 18 - 70+

Code: NCT02504879

Recruiting

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

for

Healthy Volunteers, Overweight

Location: Bethesda MD

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Sex: Female

Age: 18 - 60

Code: NCT03407079

Phase2, Recruiting

Top-Down Attentional Control of Visual-Processing

for

Focal Brain Lesion, Focal Lesions, fMRI

Location: Bethesda MD

Sponsor: National Institute of Mental Health (NIMH)

Sex: All

Age: 18 - 70+

Code: NCT01087281

Recruiting

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

for

Metastatic Colorectal Cancer

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT06149481

Phase1, Phase2, Recruiting

Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers

for

Healthy Volunteers

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 8 - 70+

Code: NCT00442195

Recruiting

Paid Clinical Trials Bethesda

Filter results

Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Men at High Genetic Risk for Prostate Cancer

Interested in new trials?

Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial

Study of Chediak-Higashi Syndrome

Effects of Treatments on Atopic Dermatitis

Clinical and Molecular Studies in Families With Inherited Eye Disease

Clinical, Genetic, and Epidemiologic Study of Children and Adults With RASopathies

Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays

Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus

Studies of the Natural History of Rheumatic Diseases

Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease

Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)

Top-Down Attentional Control of Visual-Processing

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Collection and Analysis of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers